Neuro-Oncology Reviews

Volume 23 Number 5
15 March 2021

Home > Publications > Neuro-Oncology Reviews > Volume 23, Year 2021 > Number 5, 15 March

Raguž M, Rotim A, Sajko T, Jurilj M, Splavski B, Rotim K.
Microsurgical management of a rare incidental intraventricular meningioma: a case report and relevant literature review.
Acta Clin Croat. 2021 Mar;60(1):156-160→. doi: 10.20471/acc.2021.60.01.24→. PMID: 34588738→. Case report, Review. ˍ

Danilenko M, Clifford SC, Schwalbe EC.
Inter and intra-tumoral heterogeneity as a platform for personalized therapies in medulloblastoma.
Pharmacol Ther. 2021 Mar 1:107828→. doi: 10.1016/j.pharmthera.2021.107828→. PMID: 33662447→. Review. ˍ

Lim-Fat MJ, Maralani PJ.
Is there an optimal MRI surveillance schedule for patients with high grade glioma after standard of care therapy?
Neuro Oncol. 2021 Mar 1:noab053→. doi: 10.1093/neuonc/noab053→. PMID: 33674870→. Editorial. ˍ

Ugga L, Perillo T, Cuocolo R, Stanzione A, Romeo V, Green R, Cantoni V, Brunetti A.
Meningioma MRI radiomics and machine learning: systematic review, quality score assessment, and meta-analysis.
Neuroradiology. 2021 Mar 2→. doi: 10.1007/s00234-021-02668-0→. PMID: 33649882→. Review, Meta-analysis. ˍ

Kyriakou I, Yarandi N, Polycarpou E.
Efficacy of cannabinoids against glioblastoma multiforme: A systematic review.
Phytomedicine. 2021 Mar 5:153533→. doi: 10.1016/j.phymed.2021.153533→. PMID: 33812759→. Review. ˍ

Kast RE.
Adding high dose celecoxib to increase effectiveness of standard glioblastoma chemoirradiation.
Ann Pharm Fr. 2021 Mar 6:S0003-4509(21)00042-0→. doi: 10.1016/j.pharma.2021.03.001→. PMID: 33689795→. Review˰ ˍ

Yang R, Isaacs AM, Cadieux M, Hirmer TJ, CreveCoeur TS, Lapointe AP, Opoku-Darko M, Premji Z, Riva-Cambrin J, Gallagher CN.
Primary and metastatic glioblastoma of the spine in the pediatric population: a systematic review.
Childs Nerv Syst. 2021 Mar 6→. doi: 10.1007/s00381-021-05098-8→. PMID: 33675391→. Review. ˍ

Rombi B, Ruggi A, Sardi I, Zucchelli M, Scagnet M, Toni F, Cammelli S, Giulietti G, Fabbri VP, Gianno F, Amichetti M, Yock TI, Morganti AG, Pession A, Melchionda F.
Proton therapy: A therapeutic opportunity for aggressive pediatric meningioma.
Pediatr Blood Cancer. 2021 Mar 7;68(5):e28919→. doi: 10.1002/pbc.28919→. PMID: 33682333→. Review. ˍ

Al-Gahmi A, Alhuthali M, Alrehaili M, Baltow B, Tashkandi E.
Unusual Synchronous Association of Solid Tumors with Hematological Malignancies in Multiple Primary Cancers: Case Series and Literature Review.
Case Rep Oncol. 2021 Mar 8;14(1):352-364→. doi: 10.1159/000514147→. PMID: 33776729→. Review. ˍ

Maziero D, Straza MW, Ford JC, Bovi JA, Diwanji T, Stoyanova R, Paulson ES, Mellon EA.
MR-Guided Radiotherapy for Brain and Spine Tumors.
Front Oncol. 2021 Mar 8;11:626100→. doi: 10.3389/fonc.2021.626100→. PMID: 33763361→. Review. ˍ

Tadros S, Kondrashov A, Namagiri S, Chowdhury A, Banasavadi-Siddegowda YK, Ray-Chaudhury A.
Pathological Features of Tumors of the Nervous System in Hereditary Cancer Predisposition Syndromes: A Review.
Neurosurgery. 2021 Mar 8;89(3).343-363→. doi: 10.1093/neuros/nyab019→. PMID: 33693933→. Review. ˍ

Huang B, Li X, Li Y, Zhang J, Zong Z, Zhang H.
Current Immunotherapies for Glioblastoma Multiforme.
Front Immunol. 2021 Mar 9;11:603911→. doi: 10.3389/fimmu.2020.603911→. PMID: 33767690→. Review. ˍ

Kunimatsu A, Yasaka K, Akai H, Sugawara H, Kunimatsu N, Abe O.
Texture Analysis in Brain Tumor MR Imaging.
Magn Reson Med Sci. 2021 Mar 10→. doi: 10.2463/mrms.rev.2020-0159→. PMID: 33692222→. Review. ˍ

Zhang H, Yuan F, Qi Y, Liu B, Chen Q.
Circulating Tumor Cells for Glioma.
Front Oncol. 2021 Mar 10;11:607150→. doi: 10.3389/fonc.2021.607150→. PMID: 33777749→. Review. ˍ

Banerjee K, Núñez FJ, Haase S, McClellan BL, Faisal SM, Carney SV, Yu J, Alghamri MS, Asad AS, Candia AJN, Varela ML, Candolfi M, Lowenstein PR, Castro MG.
Current Approaches for Glioma Gene Therapy and Virotherapy.
Front Mol Neurosci. 2021 Mar 11;14:621831→. doi: 10.3389/fnmol.2021.621831→. PMID: 33790740→. Review. ˍ

Biserova K, Jakovlevs A, Uljanovs R, Strumfa I.
Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma.
Cells. 2021 Mar 11;10(3):621→. doi: 10.3390/cells10030621→. PMID: 33799798→. Review. ˍ

Łaba AE, Ziółkowski P.
Trends in glioblastoma treatment research: an analysis of clinical trials and literature.
Neurol Neurochir Pol. 2021 Mar 12→. doi: 10.5603/PJNNS.a2021.0024→. PMID: 33710606→. Review. ˍ

Lozano-Ureña A, Jiménez-Villalba E, Pinedo-Serrano A, Jordán-Pla A, Kirstein M, Ferrón SR.
Aberrations of Genomic Imprinting in Glioblastoma Formation.
Front Oncol. 2021 Mar 12;11:630482→. doi: 10.3389/fonc.2021.630482→. PMID: 33777782→. Review. ˍ

McAleenan A, Kelly C, Spiga F, Kernohan A, Cheng HY, Dawson S, Schmidt L, Robinson T, Brandner S, Faulkner CL, Wragg C, Jefferies S, Howell A, Vale L, Higgins JPT, Kurian KM.
Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide.
Cochrane Database Syst Rev. 2021 Mar 12;3:CD013316→. doi: 10.1002/14651858.CD013316.pub2→. PMID: 33710615→. Review. ˍ

Shirvalilou S, Khoei S, Esfahani AJ, Kamali M, Shirvaliloo M, Sheervalilou R, Mirzaghavami P.
Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a systematic review.
J Neurooncol. 2021 Mar 13→. doi: 10.1007/s11060-021-03729-3→. PMID: 33713248→. Review. ˍ

Werbowetski-Ogilvie TE.
From sorting to sequencing in the molecular era: the evolution of the cancer stem cell model in medulloblastoma.
FEBS J. 2021 Mar 13→. doi: 10.1111/febs.15817→. PMID: 33714236→. Review. ˍ

Chaudhary R.
Potential of long non-coding RNAs as a therapeutic target and molecular markers in glioblastoma pathogenesis.
Heliyon. 2021 Mar 15;7(3):e06502→. doi: 10.1016/j.heliyon.2021.e06502→. PMID: 33786397→. Review. ˍ